FPLD3 (PPARγ gene mutation).Diabetes (median HbA1c 8.1%), hypertriglyceridemia (median TG 5.6 mmol/L), hypertension, pancreatitis, hepatic steatosis. This evidence concerns the gene PPARG and hypertriglyceridemia.